HM Golomb
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 23
- Chronic Lymphocytic Leukemia Research 23
-
- Lymphoma Diagnosis and Treatment 22
- Journals
- Blood (33 papers)PubMed (14 papers)
- Partner nations
- United StatesCanada
In The Last Decade
HM Golomb
46 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Genetics 877
- Hematology 874
- Pathology and Forensic Medicine 665
- Immunology 488
- Oncology 413
Countries citing papers authored by HM Golomb
This map shows the geographic impact of HM Golomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HM Golomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HM Golomb more than expected).
Fields of papers citing papers by HM Golomb
This network shows the impact of papers produced by HM Golomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HM Golomb. The network helps show where HM Golomb may publish in the future.
Co-authors
The 25 scholars most cited alongside HM Golomb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. | 1994 | 13 |
| 2 | 1991 | 10 | |
| 3 | 1990 | 43 | |
| 4 | Design of combination biotherapy studies: future goals and challenges. | 1990 | 9 |
| 5 | 1990 | 1 | |
| 6 | 1988 | 8 | |
| 7 | Perspective on staging approaches in the malignant lymphomas. | 1986 | 3 |
| 8 | Sequential treatment of hairy cell leukemia: a new role for interferon. | 1986 | 12 |
| 9 | 1985 | 129 | |
| 10 | Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia. | 1984 | 21 |
| 11 | Hairy cell leukemia: the importance of accurate diagnosis and sequential management. | 1984 | 2 |
| 12 | Treatment of stage IIIA Hodgkin's disease. | 1982 | 9 |
| 13 | 1982 | 127 | |
| 14 | 1981 | 24 | |
| 15 | 1981 | 43 | |
| 16 | Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease Hit paper breakdown → | 1981 | 384 |
| 17 | 1981 | 50 | |
| 18 | The treatment of histiocytic lymphoma. | 1980 | 34 |
| 19 | 1980 | 144 | |
| 20 | 1977 | 1 |
About HM Golomb
HM Golomb is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Immunology and Oncology, having authored 47 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (22 papers), Immune Cell Function and Interaction (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (7 papers), Glycosylation and Glycoproteins Research (6 papers), Viral-associated cancers and disorders (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Genetics (877 citations), Hematology (874 citations), Pathology and Forensic Medicine (665 citations), Immunology (488 citations) and Oncology (413 citations). HM Golomb has collaborated with scholars based in United States and Canada. Frequent co-authors include JW Vardiman, JD Rowley, JR Testa, J. W. Vardiman, MJ Ratain, Jacobs Rh, E. Vokes, JD Rowley, J W Vardiman and Karen Daly. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.